253
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Can pharmacotherapy improve depressive symptoms in patients with amyotrophic lateral sclerosis? A systematic review of the literature

, &
Pages 289-291 | Received 16 Sep 2015, Accepted 29 Sep 2015, Published online: 19 Nov 2015

References

  • Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ. Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:293–302.
  • Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, et al. The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: A Population Based Cohort Study. Neuroepidemiology 2015;44:91–8.
  • EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • UKMND-LiCALS Study Group, Morrison KE, Dhariwal S, Hornabrook R, Savage L, et al. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase III multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013;12:339–45.
  • Eisen A, Stewart H, Schulzer M, Cameron D. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine. Can J Neurol Sci. 1993;20:297–301.
  • Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guideline in Psychiatry, 11th edn. Wiley-Blackwell, 2012.
  • Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:481–8.
  • Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve. 2009;39:297–303.
  • Boll M-C, Bayliss L, Vargas-Cañas S, Burgos J, Montes S, Peñaloza-Solano G, et al. Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2014; 340:103–8.
  • Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I. Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12:297–302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.